194 related articles for article (PubMed ID: 10194473)
1. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.
Rittner HL; Hafner V; Klimiuk PA; Szweda LI; Goronzy JJ; Weyand CM
J Clin Invest; 1999 Apr; 103(7):1007-13. PubMed ID: 10194473
[TBL] [Abstract][Full Text] [Related]
2. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury.
Ruef J; Liu SQ; Bode C; Tocchi M; Srivastava S; Runge MS; Bhatnagar A
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1745-52. PubMed ID: 10894812
[TBL] [Abstract][Full Text] [Related]
3. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells.
Spycher SE; Tabataba-Vakili S; O'Donnell VB; Palomba L; Azzi A
FASEB J; 1997 Feb; 11(2):181-8. PubMed ID: 9039961
[TBL] [Abstract][Full Text] [Related]
5. MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.
Watanabe R; Maeda T; Zhang H; Berry GJ; Zeisbrich M; Brockett R; Greenstein AE; Tian L; Goronzy JJ; Weyand CM
Circ Res; 2018 Aug; 123(6):700-715. PubMed ID: 29970365
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.
Tammali R; Ramana KV; Singhal SS; Awasthi S; Srivastava SK
Cancer Res; 2006 Oct; 66(19):9705-13. PubMed ID: 17018629
[TBL] [Abstract][Full Text] [Related]
7. Giant cell vasculitis is a T cell-dependent disease.
Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM
Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice.
Srivastava S; Vladykovskaya E; Barski OA; Spite M; Kaiserova K; Petrash JM; Chung SS; Hunt G; Dawn B; Bhatnagar A
Circ Res; 2009 Oct; 105(8):793-802. PubMed ID: 19729598
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase prevents aldehyde toxicity in cultured human lens epithelial cells.
Pladzyk A; Ramana KV; Ansari NH; Srivastava SK
Exp Eye Res; 2006 Aug; 83(2):408-16. PubMed ID: 16631166
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vascular smooth muscle cell growth by aldose reductase.
Bhatnagar A; Ruef J; Liu S; Srivastava S; Srivastava SK
Chem Biol Interact; 2001 Jan; 130-132(1-3):627-36. PubMed ID: 11306081
[TBL] [Abstract][Full Text] [Related]
11. Torachrysone-8-O-β-d-glucoside mediates anti-inflammatory effects by blocking aldose reductase-catalyzed metabolism of lipid peroxidation products.
Zhao WL; Xu D; Wang JS
Biochem Pharmacol; 2023 Dec; 218():115931. PubMed ID: 37981172
[TBL] [Abstract][Full Text] [Related]
12. Role of lipid aldehydes in cataractogenesis: 4-hydroxynonenal-induced cataract.
Ansari NH; Wang L; Srivastava SK
Biochem Mol Med; 1996 Jun; 58(1):25-30. PubMed ID: 8809342
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the polyol pathway and non-enzymatic glycation on aortic smooth muscle cell migration and monocyte adhesion.
Dan Q; Wong R; Chung SK; Chung SS; Lam KS
Life Sci; 2004 Dec; 76(4):445-59. PubMed ID: 15530506
[TBL] [Abstract][Full Text] [Related]
14. Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal.
Srivastava S; Chandra A; Ansari NH; Srivastava SK; Bhatnagar A
Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):469-75. PubMed ID: 9445372
[TBL] [Abstract][Full Text] [Related]
15. Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells.
Srivastava S; Conklin DJ; Liu SQ; Prakash N; Boor PJ; Srivastava SK; Bhatnagar A
Atherosclerosis; 2001 Oct; 158(2):339-50. PubMed ID: 11583712
[TBL] [Abstract][Full Text] [Related]
16. Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor.
Kuruvilla R; Eichberg J
J Neurochem; 1998 Aug; 71(2):775-83. PubMed ID: 9681469
[TBL] [Abstract][Full Text] [Related]
17. Tissue-destructive macrophages in giant cell arteritis.
Rittner HL; Kaiser M; Brack A; Szweda LI; Goronzy JJ; Weyand CM
Circ Res; 1999 May; 84(9):1050-8. PubMed ID: 10325242
[TBL] [Abstract][Full Text] [Related]
18. Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries.
Borkowski A; Younge BR; Szweda L; Mock B; Björnsson J; Moeller K; Goronzy JJ; Weyand CM
Am J Pathol; 2002 Jul; 161(1):115-23. PubMed ID: 12107096
[TBL] [Abstract][Full Text] [Related]
19. Modification of aldose reductase by S-nitrosoglutathione.
Chandra A; Srivastava S; Petrash JM; Bhatnagar A; Srivastava SK
Biochemistry; 1997 Dec; 36(50):15801-9. PubMed ID: 9398310
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of aldose reductase ameliorates alcoholic liver disease by activating AMPK and modulating oxidative stress and inflammatory cytokines.
Shi C; Wang Y; Gao J; Chen S; Zhao X; Cai C; Guo C; Qiu L
Mol Med Rep; 2017 Sep; 16(3):2767-2772. PubMed ID: 28677809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
